News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
638,924 Results
Type
Article (61015)
Company Profile (72)
Press Release (577837)
Section
Business (173585)
Career Advice (2724)
Deals (32418)
Drug Delivery (95)
Drug Development (76763)
Employer Resources (148)
FDA (14887)
Job Trends (13856)
News (304619)
Policy (28891)
Tag
Academia (2874)
Alliances (43061)
Alzheimer's disease (1252)
Approvals (14883)
Artificial intelligence (204)
Bankruptcy (287)
Best Places to Work (10855)
Breast cancer (223)
Cancer (1659)
Cardiovascular disease (120)
Career advice (2304)
CAR-T (124)
Cell therapy (357)
Clinical research (61775)
Collaboration (621)
Compensation (226)
COVID-19 (2551)
C-suite (173)
Data (1594)
Diabetes (195)
Diagnostics (6073)
Earnings (59042)
Employer resources (131)
Events (93023)
Executive appointments (590)
FDA (15786)
Funding (600)
Gene therapy (239)
GLP-1 (604)
Government (4408)
Healthcare (18163)
Infectious disease (2652)
Inflammatory bowel disease (120)
Interviews (524)
IPO (14749)
Job creations (3411)
Job search strategy (1939)
Layoffs (469)
Legal (6416)
Lung cancer (241)
Manufacturing (213)
Medical device (12553)
Medtech (12558)
Mergers & acquisitions (18082)
Metabolic disorders (501)
Neuroscience (1642)
NextGen: Class of 2025 (6372)
Non-profit (4312)
Northern California (1875)
Obesity (266)
Opinion (219)
Patents (158)
People (59069)
Phase I (19429)
Phase II (27279)
Phase III (19887)
Pipeline (671)
Postmarket research (2471)
Preclinical (8225)
Radiopharmaceuticals (243)
Rare diseases (306)
Real estate (5982)
Regulatory (19740)
Research institute (2387)
Resumes & cover letters (405)
Southern California (1652)
Startups (3336)
United States (16869)
Vaccines (587)
Weight loss (176)
Date
Today (33)
Last 7 days (542)
Last 30 days (2441)
Last 365 days (31748)
2025 (4213)
2024 (32288)
2023 (36351)
2022 (46634)
2021 (51583)
2020 (50744)
2019 (44780)
2018 (34078)
2017 (30736)
2016 (30079)
2015 (35458)
2014 (28398)
2013 (24966)
2012 (26229)
2011 (26470)
2010 (24936)
Location
Africa (868)
Arizona (152)
Asia (37718)
Australia (6794)
California (4294)
Canada (1571)
China (361)
Colorado (200)
Connecticut (217)
Europe (87989)
Florida (646)
Georgia (159)
Illinois (465)
Indiana (234)
Japan (112)
Maryland (693)
Massachusetts (3132)
Michigan (200)
Minnesota (286)
New Jersey (1278)
New York (1251)
North Carolina (828)
Northern California (1875)
Ohio (163)
Pennsylvania (981)
South America (1173)
Southern California (1652)
Texas (656)
Utah (135)
Washington State (428)
638,924 Results for "university of oxford".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
SpyBiotech Adds Epstein-Barr Virus Research and Development Collaboration with The University of Oxford
SpyBiotech, a biotechnology company with novel vaccine platform technologies that can target infectious diseases, cancer, and chronic diseases, announced a sponsored research agreement with The University of Oxford for the development of a vaccine against Epstein-Barr virus.
May 23, 2024
·
4 min read
Press Releases
Sparrow Pharmaceuticals Collaborates with the University of Oxford and the University of Sheffield on DC-MACS, a Phase 2 Clinical Study of Clofutriben
December 11, 2024
·
4 min read
Press Releases
Top Neuroscientist Matthew Anderson Appointed Co-Director of the Oxford-Harrington Rare Disease Centre
February 19, 2025
·
3 min read
Press Releases
Oxford BioDynamics’ EpiSwitch® CRC Blood Test Accurately Detects both Cancer and Polyps
February 5, 2025
·
5 min read
Press Releases
Boehringer Ingelheim Acquires Fourth License for the Development of Novel Antibody Based Cancer Treatments from Oxford BioTherapeutics
January 9, 2025
·
3 min read
Oxford Nanopore Technologies Collaborates With Twist Bioscience to Launch Pharmacogenomics Beta Programme and Advance Personalised Medicine
Oxford Nanopore Technologies announced the launch of a new Pharmacogenomics Beta Program to advance personalised medicine, combining Twist Bioscience’s next generation sequencing target enrichment technology with Oxford Nanopore’s sequencing platform.
May 22, 2024
·
3 min read
Oxford BioDynamics Develops a High Accuracy, Discriminating Diagnostic Test for Multiple Canine Cancers
Oxford BioDynamics Plc, a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D genomics platform, announces development of a high-accuracy, discriminating multi-cancer canine diagnostic test for veterinary medicine.
June 4, 2024
·
4 min read
Business
Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK
Azenta, Inc. announced the grand opening of the new Genomics Laboratory in Oxford, UK, expanding its global reach of GENEWIZ Multiomics & Synthesis Solutions further in the UK market.
May 13, 2024
·
3 min read
BioMidwest
The Oxford-Harrington Rare Disease Centre Launches Pioneering Therapeutics Accelerator to Advance Innovative Treatments for Rare Diseases
The University of Oxford and Harrington Discovery Institute at University Hospitals in Cleveland, Ohio announced the launch of the Oxford-Harrington Rare Disease Centre Therapeutics Accelerator with an official signing event at the University of Oxford.
October 3, 2023
·
12 min read
Press Releases
BPGbio and University of Oxford Enter into Strategic Collaboration Focused on Breakthrough E2-based Protein Degradation Research in Oncology and CNS Diseases
October 8, 2024
·
4 min read
1 of 63,893
Next
